Nomura Mid Cap Income Opps C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Nomura Mid Cap Income Opportunities Fund Class C IVOCX
- NAV / 1-Day Return 17.79 / +0.06 %
- Total Assets 635.8M
-
Adj. Expense Ratio
1.820%
- Expense Ratio 1.830%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Mid-Cap Blend
- Investment Style Mid Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.02%
- Turnover 22%
USD | NAV as of Oct 06, 2026 | 1-Day Return as of Oct 06, 2026, 12:11 AM GMT+0
Morningstar’s Analysis IVOCX
Will IVOCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 31.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
SLB Ltd | 3.62 | 25M | Energy |
Arthur J. Gallagher & Co | 3.33 | 23M | Financial Services |
Royalty Pharma PLC Class A | 3.24 | 22M | Healthcare |
Quest Diagnostics Inc | 3.18 | 22M | Healthcare |
Ares Management Corp Ordinary Shares - Class A | 3.15 | 21M | Financial Services |
Coca-Cola Europacific Partners PLC | 3.15 | 21M | Consumer Defensive |
Broadridge Financial Solutions Inc | 3.15 | 21M | Technology |
Paychex Inc | 3.13 | 21M | Technology |
AptarGroup Inc | 3.01 | 20M | Healthcare |
TE Connectivity PLC Registered Shares | 2.98 | 20M | Technology |
United States